Rationale and Design of the GISSI Heart Failure Trial: A Large Trial to Assess the Effects of n-3 Polyunsaturated Fatty Acids and Rosuvastatin in Symptomatic Congestive Heart Failure — Luigi Tavazzi (2004) | RDL Network
Rationale and Design of the GISSI Heart Failure Trial: A Large Trial to Assess the Effects of n-3 Polyunsaturated Fatty Acids and Rosuvastatin in Symptomatic Congestive Heart Failure
Article 2004 en
Authors
LT
Luigi Tavazzi
GT
Gianni Tognoni
MF
Maria Grazia Franzosi
Abstract
1 min read
The GISSI-HF project, with its protocol articulated into two independent randomization schemes, has the aim and the power to verify the hypothesis that n-3 polyunsaturated fatty acids and rosuvastatin can favorably modify the prognosis of patients with symptomatic heart failure.
Roberto Marchioli, Giacomo Levantesi, Maria G Silletta, Simona Barlera, Marino Bernardinangeli, Emanuele Carbonieri, Francesco Cosmi, Maria Grazia Franzosi, Roberto Latini, Donata Lucci, Aldo Maggioni, Luciano Moretti, Gian Luigi Nicolosi, Maurizio Porcu, Maria Grazia Rossi, Gianni Tognoni, Luigi Tavazzi
Roberto Marchioli, Rosa Maria Marfisi, Giovanna Borrelli, Carmelo Chieffo, Maria Grazia Franzosi, Giacomo Levantesi, Aldo Maggioni, Gian Luigi Nicolosi, Marco Scarano, Maria Giuseppina Silletta, Carlo Schweiger, Luigi Tavazzi, Gianni Tognoni
Discussion(0)
No comments yet. Be the first to comment.